Detalhe da pesquisa
1.
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma.
Gastroenterology
; 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244727
2.
Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma.
Oncologist
; 28(2): e115-e123, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427020
3.
Phase 1/1b open-label, dose-escalation study of fruquintinib in patients with advanced solid tumors in the United States.
Invest New Drugs
; 41(6): 851-860, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796398
4.
Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study.
Invest New Drugs
; 39(5): 1298-1305, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33738668
5.
Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma.
Ann Surg
; 272(3): 481-486, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32740235
6.
Utility of Endoscopic Ultrasound in Evaluating Local Recurrence After Surgery for Pancreatic Cancer.
Clin Gastroenterol Hepatol
; 16(11): 1834-1835, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29505906
7.
Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis.
Br J Cancer
; 116(10): 1247-1253, 2017 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28350787
8.
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
Lancet
; 387(10018): 545-557, 2016 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26615328
9.
PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.
Radiology
; 282(2): 453-463, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27841728
10.
Trends in Neoadjuvant Approaches in Pancreatic Cancer.
J Natl Compr Canc Netw
; 15(8): 1070-1077, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28784867
11.
Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study.
HPB (Oxford)
; 19(2): 133-139, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27916436
12.
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.
Lancet Oncol
; 17(6): 801-810, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27160474
13.
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.
Lancet Oncol
; 17(5): 651-62, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27055731
14.
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors.
Invest New Drugs
; 34(1): 84-95, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26620496
15.
Natural history of preoperative subcentimeter pulmonary nodules in patients with resectable pancreatic adenocarcinoma: a retrospective cohort study.
Ann Surg
; 261(5): 970-5, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24950261
16.
Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study.
Invest New Drugs
; 33(4): 963-8, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25952464
17.
A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma.
HPB (Oxford)
; 17(7): 587-93, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25800066
18.
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer.
Cancer Immunol Immunother
; 63(5): 513-28, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24652403
19.
PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.
Radiology
; 291(1): 271, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30897045
20.
Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors.
Invest New Drugs
; 32(6): 1236-45, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25117475